The type 2 diabetes medication Ozempic has been hugely popular when prescribed off-label for weight loss, thanks to its ability to regulate your blood sugar and curb your appetite. But between ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults worldwide who heard about Novo Nordisk’s ...

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...

Metformin is one of the most widely sold prescription drugs in the United States. Its main purpose is to improve insulin sensitivity and control blood glucose levels. But using Metformin for weight ...

Medications like Ozempic and Wegovy have made waves for weight loss, but they’re not for everyone. If you’ve been put off by side effects, supply issues, high costs or you just don’t like the idea of ...

Medically reviewed by Erika Prouty, PharmD Key Takeaways Metformin helps control blood sugar by reducing glucose absorption, production, and increasing insulin sensitivity.Metformin is a popular first ...

Metformin is the most widely prescribed drug in the world to treat Type 2 diabetes, and it's been around for more than 60 years. But now, researchers are learning more about this popular medicine's ...

Treatment of gestational diabetes with metformin, and glyburide if needed, does not meet noninferiority criteria versus insulin. (HealthDay News) — With respect to the proportion of infants born large ...

Is an ancient compound the new “wonder drug”? Metformin, a common medication to control diabetes, has become the controversial darling of tech’s health-conscious digerati who are enticed by ...

The surprising findings could improve how doctors manage type 1 diabetes and ease the significant burden that people with the condition face when using insulin alone. In their published paper in ...

Overall, 79% of the participants randomly assigned to oral agents maintained glycemic control without insulin. Doortje Rademaker, MD, from the Amsterdam University Medical Center, and colleagues ...